125 related articles for article (PubMed ID: 12595085)
1. Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells.
Lotero LA; Olmos G; Diez JC
Biochim Biophys Acta; 2003 Mar; 1620(1-3):160-6. PubMed ID: 12595085
[TBL] [Abstract][Full Text] [Related]
2. Delivery to macrophages of interleukin 3 loaded in mouse erythrocytes.
Olmos G; Lotero LA; Tejedor MC; Diez JC
Biosci Rep; 2000 Oct; 20(5):399-410. PubMed ID: 11332601
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking treatment of loaded erythrocytes increases delivery of encapsulated substance to macrophages.
Alvarez FJ; Jordán JA; Calleja P; Lotero LA; Olmos G; Díez JC; Tejedor MC
Biotechnol Appl Biochem; 1998 Apr; 27(2):139-43. PubMed ID: 9569609
[TBL] [Abstract][Full Text] [Related]
4. Hypotonically loaded rat erythrocytes deliver encapsulated substances into peritoneal macrophages.
Alvarez FJ; Jordán JA; Herráez A; Díez JC; Tejedor MC
J Biochem; 1998 Feb; 123(2):233-9. PubMed ID: 9538197
[TBL] [Abstract][Full Text] [Related]
5. In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross-linking or diamide treatment.
Jordán JA; Alvarez FJ; Lotero LA; Herráez A; Díez JC; Tejedor MC
Biotechnol Appl Biochem; 2001 Dec; 34(3):143-9. PubMed ID: 11730481
[TBL] [Abstract][Full Text] [Related]
6. Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes.
Briones E; Colino CI; Millán CG; Lanao JM
Eur J Pharm Sci; 2009 Nov; 38(4):320-4. PubMed ID: 19712742
[TBL] [Abstract][Full Text] [Related]
7. Toxic action of etoposide on mouse peritoneal macrophages and its modulation by interleukin 3.
Olmos G; Lotero LA; Herráez A; Diez JC
Cell Biochem Funct; 2004; 22(1):45-52. PubMed ID: 14695654
[TBL] [Abstract][Full Text] [Related]
8. Differential induction of macrophage recognition of carrier erythrocytes by treatment with band 3 cross-linkers.
Jordán JA; Alvarez FJ; Lotero LA; Olmos G; Calleja P; Tejedor MC; Díez JC
Biotechnol Appl Biochem; 1998 Apr; 27(2):133-7. PubMed ID: 9569608
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis.
Gutiérrez Millán C; Zarzuelo Castañeda A; Sayalero Marinero ML; Lanao JM
Blood Cells Mol Dis; 2004; 33(2):132-40. PubMed ID: 15315791
[TBL] [Abstract][Full Text] [Related]
10. Drug, enzyme and peptide delivery using erythrocytes as carriers.
Millán CG; Marinero ML; Castañeda AZ; Lanao JM
J Control Release; 2004 Feb; 95(1):27-49. PubMed ID: 15013230
[TBL] [Abstract][Full Text] [Related]
11. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
Wang Z; Li Z; Zhang D; Miao L; Huang G
Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-based drug delivery.
Rossi L; Serafini S; Pierigé F; Antonelli A; Cerasi A; Fraternale A; Chiarantini L; Magnani M
Expert Opin Drug Deliv; 2005 Mar; 2(2):311-22. PubMed ID: 16296756
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
15. Erythrocyte engineering for drug delivery and targeting.
Magnani M; Rossi L; D'ascenzo M; Panzani I; Bigi L; Zanella A
Biotechnol Appl Biochem; 1998 Aug; 28(1):1-6. PubMed ID: 9693082
[TBL] [Abstract][Full Text] [Related]
16. Band-3 crosslinking-induced targeting of mouse carrier erythrocytes.
Jordán JA; Alvarez FJ; Tejedor MC; Díez JC
Biotechnol Appl Biochem; 1999 Feb; 29(1):59-65. PubMed ID: 10206650
[TBL] [Abstract][Full Text] [Related]
17. Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake.
Mishra PR; Jain NK
J Drug Target; 2000; 8(4):217-24. PubMed ID: 11144232
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Zhang S; Lu C; Zhang X; Li J; Jiang H
Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes.
Millán CG; Castañeda AZ; López FG; Marinero ML; Lanao JM; Arévalo M
Drug Deliv; 2005; 12(6):409-16. PubMed ID: 16253957
[TBL] [Abstract][Full Text] [Related]
20. Study of the factors influencing the encapsulation of zidovudine in rat erythrocytes.
Briones E; Colino CI; Lanao JM
Int J Pharm; 2010 Nov; 401(1-2):41-6. PubMed ID: 20854886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
